We partner with international pharmaceutical companies to act as Swiss marketing authorization holder (MAH) and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced and provide in-depth expertise of commercial operations in domains like oncology and rare diseases
- http://www.sfl-pharma.ch
- +41 61 544 47 20
- info@sfl-pharma.ch
- Shayesteh Fürst-Ladani